- In January 2024, JW Life Science committed USD 100 million to expand its manufacturing capacity for large-volume parenterals (LVPs), addressing the global shortage of intravenous solutions and meeting the rising demand for critical care medications.
- In December 2023, Fresenius Kabi AG acquired Ivensa, a Spanish pharmaceutical company specializing in sterile injectables, for EUR 485 million. This acquisition enhances Fresenius Kabi's product portfolio in intravenous solutions, strengthening its market position in Spain
- In July 2014, the European Union's RoHS II Directive (2011/65/EU) mandated that medical devices comply with restrictions on hazardous substances, including lead, mercury, and cadmium, to promote environmental sustainability. In August 2018, the WEEE Directive (2012/19/EU) required all electrical and electronic equipment, including medical devices, to adhere to collection, recycling, and recovery targets to minimize e-waste
- In January 2017, the U.S. FDA introduced the Digital Health Innovation Action Plan to streamline the review process for digital health devices, including those integrated with medical stopcocks, fostering innovation in healthcare technology
